Short review. Prospects for cancer immunochemotherapy

The interaction of oestrogen receptor status and pathological features with adjuvant treatment in relation to survival in patients with operable breast cancer: a retrospective study of 2660 patients.

Endocrine-related cancer·2004

Epirubicin in patients with liver dysfunction: development and evaluation of a novel dose modification scheme.

European journal of cancer (Oxford, England : 1990)·2003

7. Management of advanced breast cancer.

International journal of clinical practice·2002

Metastatic eccrine porocarcinoma: response to docetaxel (Taxotere) chemotherapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2001

Risk of complications from bone metastases in breast cancer. implications for management.

European journal of cancer (Oxford, England : 1990)·2000

Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancer.

British journal of cancer·1999

Vinorelbine and low-dose cyclophosphamide as maintenance therapy in the treatment of Ewing sarcoma rationale for the international INTER-EWING-1 trial for Ewing sarcoma patients.

Cancer treatment reviews·2026

Is Cytoreductive surgery for unresectable colorectal liver metastases able to improve patient outcome? Results of a pilot prospective study.

Cancer treatment reviews·2026

Chondrosarcoma: A comprehensive review of tumor biology, clinical behavior, and therapeutic advances.

Cancer treatment reviews·2026

Pharmacological prevention of second primary cancers: From chemoprevention to precision cancer interception.

Cancer treatment reviews·2026

Understanding extrapulmonary neuroendocrine carcinomas: Survival, prognosis, and patient quality of life.

Cancer treatment reviews·2026

Comparative analysis of patient-derived organoids and patient-derived xenografts as avatar models for predicting response to anti-cancer therapy.

Cancer treatment reviews·2026

Immune profiling by bulk RNA-seq and multiplex immunofluorescence imaging across multiple cancer types.

Frontiers in oncology·2026

Brain barriers at the crossroads of glioma immune surveillance and immunotherapy response.

Nature reviews. Cancer·2026

Circulating levels of TL1A and its decoy receptor DcR3 in systemic sclerosis.

Clinical rheumatology·2026

Erratum to 'Clinical and Immunologic Features of Primary Enteric-Type Thymic Adenocarcinomas: A Rare Variant of a Rare Cancer' [JTO Clinical and Research Reports 7 (2026) 101019].

JTO clinical and research reports·2026

Mathematical and Mouse Models Identify Regulatory T Cell Influx as A Key Determinant of Acquired Resistance to PD-1 Immunotherapy.

Cancer research·2026

Peripheral cytokine distinguish recent from Mycobacterium tuberculosis infection and active tuberculosis.

Frontiers in microbiology·2026

Related Experiment Videos

Short review. Prospects for cancer immunochemotherapy

Related Concept Videos

The interaction of oestrogen receptor status and pathological features with adjuvant treatment in relation to survival in patients with operable breast cancer: a retrospective study of 2660 patients.

Epirubicin in patients with liver dysfunction: development and evaluation of a novel dose modification scheme.

7. Management of advanced breast cancer.

Metastatic eccrine porocarcinoma: response to docetaxel (Taxotere) chemotherapy.

Risk of complications from bone metastases in breast cancer. implications for management.

Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancer.

Vinorelbine and low-dose cyclophosphamide as maintenance therapy in the treatment of Ewing sarcoma rationale for the international INTER-EWING-1 trial for Ewing sarcoma patients.

Is Cytoreductive surgery for unresectable colorectal liver metastases able to improve patient outcome? Results of a pilot prospective study.

Chondrosarcoma: A comprehensive review of tumor biology, clinical behavior, and therapeutic advances.

Pharmacological prevention of second primary cancers: From chemoprevention to precision cancer interception.

Understanding extrapulmonary neuroendocrine carcinomas: Survival, prognosis, and patient quality of life.

Comparative analysis of patient-derived organoids and patient-derived xenografts as avatar models for predicting response to anti-cancer therapy.

Immune profiling by bulk RNA-seq and multiplex immunofluorescence imaging across multiple cancer types.

Brain barriers at the crossroads of glioma immune surveillance and immunotherapy response.

Circulating levels of TL1A and its decoy receptor DcR3 in systemic sclerosis.

Erratum to 'Clinical and Immunologic Features of Primary Enteric-Type Thymic Adenocarcinomas: A Rare Variant of a Rare Cancer' [JTO Clinical and Research Reports 7 (2026) 101019].

Mathematical and Mouse Models Identify Regulatory T Cell Influx as A Key Determinant of Acquired Resistance to PD-1 Immunotherapy.

Peripheral cytokine distinguish recent from Mycobacterium tuberculosis infection and active tuberculosis.

Related Experiment Videos

Short review. Prospects for cancer immunochemotherapy

Related Concept Videos

Related Articles